Insights Into Patient Variability During Ivacaftor-Lumacaftor Therapy in Cystic Fibrosis
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2021.577263
Abstract: Background: The advent of cystic fibrosis transmembrane conductance regulator protein (CFTR) modulators like ivacaftor have revolutionised the treatment of cystic fibrosis (CF). However, due to the plethora of variances in disease manifestations in CF, there… read more here.
Keywords: ivacaftor; cystic fibrosis; variability; lumacaftor ... See more keywords